Section Arrow
Quote
TAK.NYSE
- Takeda Pharmaceutical Company Limited
Quotes are at least 15-min delayed:2025/11/16 13:32 EST
Regular Hours
Last
 14.29
+0.05 (+0.35%)
Day High 
14.41 
Prev. Close
14.24 
1-M High
14.3155 
Volume 
2.66M 
Bid
13.91
Ask
14.99
Day Low
14.27 
Open
14.36 
1-M Low
12.99 
Market Cap 
44.99B 
Currency USD 
P/E 213.52 
%Yield 2.37 
10-SMA 13.74 
20-SMA 13.85 
50-SMA 14.36 
52-W High 15.69 
52-W Low 12.8 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
10.29/220.99
Enterprise Value
4,011.31B
Balance Sheet
Book Value Per Share
14.65
Cash Flow
Cash Flow Yield
0.17
Income Statement
Total Revenue
4,581.55B
Operating Revenue Per Share
8.80
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands1.08-0.05-4.42%-- 
HIMSHims & Hers Health36.98+0.93+2.58%68.21PE
CGCCanopy Growth Corp1.07-0.03-2.73%-- 
AKBAAkebia Therapeutics1.67-0.09-5.11%-- 
AVDLAvadel Pharmaceuticals plc23.56+4.32+22.45%-- 
Quotes are at least 15-min delayed：2025/11/16 13:32 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.